NCT06768177Enrolling by invitation
Platelet Rich Plasma (PRP) as Terapeutical Option in Erectil Disfunction (DE)
Source: ClinicalTrials.gov · Last updated 2 Oct 2025 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
Patients are randomized into 2 groups (A and B), subsequently group A is subjected to a cycle of 6 weekly injections of 3 ml of autologous PRP while group B is subjected to 6 weekly injections of 1 ml of caverject (alprostadil) 20 mcg. After 4 (four) weeks the groups will be crossed, so group A will be subjected to 6 weekly injections of 1 ml of caverject (alprostadil) 20 mcg while group B will be subjected to a cycle of 6 weekly injections of 3 ml of autologous PRP.
- Status (registry)
- Enrolling by invitation
- Study type
- Interventional
- Enrollment
- 60 (estimated)
- First submitted
- 3 Dec 2024
- Start date
- 1 Apr 2023
- Primary completion date
- 1 Nov 2024
- Lead sponsor
- Azienda Ospedaliero-Universitaria Consorziale Policlinico di Bari
- Diseases
- Type 2 diabetes
- NCT number
- NCT06768177
What you commit to
- Study type: Interventional
- Planned participants: 60
- From 1 Apr 2023 to the primary completion date, 1 Nov 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Patients on antidepressant, anxiolytic, sedative, or antipsychotic medications.
Other
- Consumers of more than 500 g of alcohol per day.
- BMI greater than 35
- Altered levels of FSH, LH, PRL, Total Testosterone, and TSH.
Who the study is looking for
- Moderate to severe erectile dysfunction (IIEF-5 score below 17)
- Patients previously treated with first- and second-line therapies for ED
- Patients who have undergone radical pelvic surgery with nerve sparing
- Good pharmacological blood pressure control
- Well-controlled diabetes on medication
- Current or former smokers
- Good renal function even with the use of medications
- Well-controlled hypertriglyceridemia and/or hypercholesterolemia even with the use of medications
- BMI less than or equal to 35
- Normal levels of FSH, LH, PRL, Total Testosterone, and TSH
Age in the registry: 30 years to - · Sex: Male · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Policlinico di Bari - Azienda Ospedaliero Universitaria Consorziale Policlinico Coordinator of this site? Confirm its status | Bari | Italy | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.